Naloxone Injection Ampoules 400mcg/ml are supplied in 1ml clear glass ampoules, with each ampoule containing 0.4mg naloxone hydrochloride. Intended for use in suspected opioid overdose and opioid-induced respiratory or central nervous system depression, this solution for injection or infusion is available in packs of 10 and should be stored below 25°C in the outer carton to protect from light.
Naloxone Injection Ampoules 400mcg/ml are supplied as a sterile solution for injection or infusion in 1ml clear glass ampoules. Each ampoule contains 0.4mg naloxone hydrochloride, with sodium chloride, diluted hydrochloric acid and water for injections as excipients.
This product is used in clinical settings where opioid exposure is suspected or confirmed, including cases involving respiratory or central nervous system depression. It may also be used when assessing suspected acute opioid overdose or intoxication, and in neonatal care where opioid-related respiratory depression is being managed following maternal opioid use.
The ampoules should be stored in the outer carton to protect them from light and kept below 25°C. Once opened, the product should be used immediately. Diluted solutions should also be stored below 25°C and, where not used straight away, handled in line with appropriate storage and aseptic preparation requirements.
Naloxone Injection Ampoules 400mcg/ml are intended for use by trained healthcare professionals and organisations that need naloxone available for emergency response and clinical care. This may include hospitals, ambulance services, clinics, healthcare settings and other professional environments where opioid overdose may need to be managed.
It is used where the complete or partial reversal of opioid-related central nervous system depression, particularly respiratory depression, is required. It may also be used when acute opioid overdose or intoxication is suspected, and in neonatal care where opioid-related respiratory or central nervous system depression needs to be addressed under appropriate clinical supervision.
| Specification | Details |
| Pack Size | Pack of 10 ampoules |
| Form | Solution for injection / infusion |
| Strength | 400 micrograms per ml |
| Active Ingredient | Naloxone hydrochloride (as dihydrate) |
| Excipients | Sodium chloride, diluted hydrochloric acid, water for injections |
| Ampoule Size | 1ml |
| Storage | Store below 25°C |
Naloxone Injection Ampoules 400mcg/ml are used in cases of suspected opioid overdose or opioid intoxication. They may also be used where opioid-related breathing or central nervous system depression is suspected.
Each 1ml ampoule contains 400 micrograms of naloxone hydrochloride (as dihydrate).
Store below 25°C and keep the ampoules in the outer carton to protect them from light.